An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma
Witzig, T.E., Vose, J.M., Zinzani, P.L., Reeder, C.B., Buckstein, R., Polikoff, J.A., Bouabdallah, R., Haioun, C., Tilly, H., Guo, P., Pietronigro, D., Ervin-Haynes, A.L., Czuczman, M.S.
Published in Annals of oncology (01.07.2011)
Published in Annals of oncology (01.07.2011)
Get full text
Journal Article
Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study
Zinzani, P.L., Vose, J.M., Czuczman, M.S., Reeder, C.B., Haioun, C., Polikoff, J., Tilly, H., Zhang, L., Prandi, K., Li, J., Witzig, T.E.
Published in Annals of oncology (01.11.2013)
Published in Annals of oncology (01.11.2013)
Get full text
Journal Article
Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy
CZUCZMAN, M. S, GRILLA-LOPEZ, A. J, WHITE, C. A, SALEH, M, GORDON, L, LOBUGLIO, A. F, JONAS, C, KLIPPENSTEIN, D, DALLAIRE, B, VARNS, C
Published in Journal of clinical oncology (01.01.1999)
Published in Journal of clinical oncology (01.01.1999)
Get full text
Journal Article
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness
Czuczman, M.S., Leonard, J.P., Jung, S., Johnson, J.L., Hsi, E.D., Byrd, J.C., Cheson, B.D.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program
McLaughlin, P, Grillo-López, A J, Link, B K, Levy, R, Czuczman, M S, Williams, M E, Heyman, M R, Bence-Bruckler, I, White, C A, Cabanillas, F, Jain, V, Ho, A D, Lister, J, Wey, K, Shen, D, Dallaire, B K
Published in Journal of clinical oncology (01.08.1998)
Published in Journal of clinical oncology (01.08.1998)
Get more information
Journal Article
Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment
DAVIS, T. A, GRILLO-LOPEZ, A. J, WHITE, C. A, MCLAUGHLIN, P, CZUCZMAN, M. S, LINK, B. K, MALONEY, D. G, WEAVER, R. L, ROSENBERG, J, LEVY, R
Published in Journal of clinical oncology (17.09.2000)
Published in Journal of clinical oncology (17.09.2000)
Get full text
Journal Article
Rituximab in Combination With Fludarabine Chemotherapy in Low-Grade or Follicular Lymphoma
CZUCZMAN, M. S, KORYZNA, A, SKIPPER, M, BROWN, K, CHANAN-KHAN, A, KLIPPENSTEIN, D, LOUD, P, ROCK, M. K, BENYUNES, M, GRILLO-LOPEZ, A, BERNSTEIN, S. H, MOHR, A, STEWART, C, DONOHUE, K, BLUMENSON, L, BERNSTEIN, Z. P, MCCARTHY, P, ALAM, A, HERNANDEZ-ILIZALITURRI, F
Published in Journal of clinical oncology (01.02.2005)
Published in Journal of clinical oncology (01.02.2005)
Get full text
Journal Article
A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma
Witzig, T.E., Nowakowski, G.S., Habermann, T.M., Goy, A., Hernandez-Ilizaliturri, F.J., Chiappella, A., Vitolo, U., Fowler, N., Czuczman, M.S.
Published in Annals of oncology (01.08.2015)
Published in Annals of oncology (01.08.2015)
Get full text
Journal Article
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients
HAHN, T, RONDEAU, C, CZUCZMAN, M. S, SLACK, J, WETZLER, M, MOOKERJEE, B. K, SILVA, J, MCCARTHY, P. L, SHAUKAT, A, JUPUDY, V, MILLER, A, ALAM, A. R, BAER, M. R, BAMBACH, B, BERNSTEIN, Z, CHANAN-KHAN, A. A
Published in Bone marrow transplantation (Basingstoke) (01.08.2003)
Published in Bone marrow transplantation (Basingstoke) (01.08.2003)
Get full text
Journal Article
Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma
BENEKLI, M, SMILEY, S. L, YOUNIS, T, CZUCZMAN, M. S, HERNANDEZ-ILIZALITURRI, F, BAMBACH, B, BATTIWALLA, M, PADMANABHAN, S, MCCARTHY, P. L, HAHN, T
Published in Bone marrow transplantation (Basingstoke) (01.04.2008)
Published in Bone marrow transplantation (Basingstoke) (01.04.2008)
Get full text
Journal Article
Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes
Pfeifer, M, Zheng, B, Erdmann, T, Koeppen, H, McCord, R, Grau, M, Staiger, A, Chai, A, Sandmann, T, Madle, H, Dörken, B, Chu, Y-W, Chen, A I, Lebovic, D, Salles, G A, Czuczman, M S, Palanca-Wessels, M C, Press, O W, Advani, R, Morschhauser, F, Cheson, B D, Lenz, P, Ott, G, Polson, A G, Mundt, K E, Lenz, G
Published in Leukemia (01.07.2015)
Published in Leukemia (01.07.2015)
Get full text
Journal Article
Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation : possible beneficial use of low molecular weight heparin
SIMON, M, HAHN, T, SLACK, J. L, WETZLER, M, HERZIG, G, SCHRIBER, J, MCCARTHY, P. L, FORD, L. A, ANDERSON, B, SWINNICH, D, BAER, M. R, BAMBACH, B, BERNSTEIN, S. H, BERNSTEIN, Z. P, CZUCZMAN, M. S
Published in Bone marrow transplantation (Basingstoke) (01.03.2001)
Published in Bone marrow transplantation (Basingstoke) (01.03.2001)
Get full text
Journal Article
A Phase 1b 2 trial of mapatumumab in patients with relapsed refractory non-Hodgkin's lymphoma
Younes, A, Vose, J M, Zelenetz, A D, Smith, M R, Burris, H A, Ansell, S M, Klein, J, Halpern, W, Miceli, R, Kumm, E, Fox, N L, Czuczman, M S
Published in British journal of cancer (07.12.2010)
Published in British journal of cancer (07.12.2010)
Get full text
Journal Article
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
Czuczman, M. S., Grillo-López, A. J., McLaughlin, P., White, C. A., Saleh, M., Gordon, L., LoBuglio, A. F., Rosenberg, J., Alkuzweny, B., Maloney, D.
Published in Annals of oncology (01.01.2001)
Published in Annals of oncology (01.01.2001)
Get full text
Journal Article
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness
Czuczman, M S, Leonard, J P, Jung, S, Johnson, J L, Hsi, E D, Byrd, J C, Cheson, B D
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease
HAHN, T, BENEKLI, M, WETZLER, M, BECKER, J. L, MCCARTHY, P. L, WONG, C, MOYSICH, K. B, HYLAND, A, MICHALEK, A. M, ALAM, A, BAER, M. R, BAMBACH, B, CZUCZMAN, M. S
Published in Bone marrow transplantation (Basingstoke) (01.03.2005)
Published in Bone marrow transplantation (Basingstoke) (01.03.2005)
Get full text
Journal Article
Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patients
BENEKLI, M, HAHN, T, SHAFI, F, QURESHI, A, ALAM, A. R, CZUCZMAN, M. S, BERNSTEIN, Z. P, CHANAN-KHAN, A. A, BECKER, J. L, MCCARTHY, P. L
Published in Bone marrow transplantation (Basingstoke) (02.07.2003)
Published in Bone marrow transplantation (Basingstoke) (02.07.2003)
Get full text
Journal Article